Progress
“Thanks to national NTD integration efforts and public–private partnerships between national NTD programs, USAID and other funders, pharmaceutical companies and international NTD control program administrators such as END in Africa, per-person MDA costs have been cut by more than 50 percent, from 27 cents to just 12 cents.”
Photo Credit: FHI 360
Ghana and Togo have already stopped mass treatments for at least one NTD
Since 2012, END in Africa has conducted 354 disease assessments to track the decline of NTDs in its countries in Africa. As disease prevalence is reduced below World Health Organization thresholds, countries can stop mass treatments. However, they still need to keep up surveillance to ensure the diseases don't return.
Photo Credit: FHI 360
Progress In Numbers
464 million
Treatments delivered*
* Treatment with one of five drugs: ivermectin, albendazole, praziquantel, azithromycin or tetracycline.
221 million
People treated
